Clover Health Investments Corp.

CLOV | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.54

+$0.08 (+1.79%)

At close: Sep 21, 2026, 4:00 PM ET

$4.56

+$0.02 (+0.48%)

Pre-market: Sep 22, 2026, 6:57 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $2.31B

Enterprise Value $2.15B

Beta 2.48

Average Volume 6.42M

Shares Outstanding (Diluted) 545.45M

Shares Change YoY 7.18%

Institutional Ownership 24.41%

Exchange NASDAQ

ISIN US18914F1030

Price Performance

Price Change 1M 9.1%

Price Change 3M -10.3%

Price Change 6M 149.4%

Price Change YTD 88.4%

Price Change 1Y 51.3%

Price Change 3Y 312.7%

Price Change 5Y -41.3%

1M CAGR (ann.) -4.3%

1Y CAGR (ann.) 45.3%

5Y CAGR (ann.) -12.3%

All-Time CAGR -12.4%

Valuation

PE Ratio -109.13

Forward PE 44.62

PEG Ratio 5.49

Forward PEG -1.39

PS Ratio 0.95

Forward PS 0.70

PB Ratio 6.25

P/FCF Ratio 12.98

P/Adj. FCF Ratio 24.36

P/OCF Ratio 30.27

EV/Sales 0.87

EV/EBIT -117.18

EV/EBITDA -130.74

EV/FCF 11.87

Earnings Yield -0.9%

FCF Yield 7.7%

Adj. FCF Yield 4.1%

Financial Health

Net Cash $201.32M

Total Debt $0

Cash & Short-Term Investments $201.32M

Total Assets $720.33M

Current Ratio 1.50

Quick Ratio 1.50

Debt / Equity Ratio 0.00

Debt / EBITDA -0.00

Debt / FCF 0.00

OCF / Debt N/A

Interest Coverage 0.00

Altman Z-Score 3.32

Piotroski F-Score 4

Margins & Profitability

Gross Profit Margin 18.6%

Operating Profit Margin -0.7%

EBITDA Margin -0.7%

Net Profit Margin -0.7%

FCF Margin 7.3%

Adj. FCF Margin 3.9%

SBC / Revenue 2.9%

SBC Impact (per share) -46.7%

Returns

Return on Assets -2.5%

Return on Equity -5.4%

Return on Invested Capital -4.6%

Return on Capital Employed -4.6%

Return on Tangible Assets -2.6%

Historical Growth (CAGR)

Revenue CAGR 3Y 1.1%

Revenue CAGR 5Y 21.2%

Revenue CAGR 10Y N/A

EPS CAGR 3Y 86.0%

EPS CAGR 5Y 58.0%

EPS CAGR 10Y N/A

FCF CAGR 3Y 109.4%

FCF CAGR 5Y 133.7%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Hold

Analyst Count 9

EPS Growth Next 3Y 233.3%

Revenue Growth Next 3Y 20.4%

Earnings Date N/A

EPS Estimate (next Q) N/A

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $5.50

Price Target Upside 21.1%

Cash Flow

Operating Cash Flow $184.93M

Free Cash Flow $181.25M

Adj. Free Cash Flow $96.6M

FCF Per Share $0.14

OCF Per Share $0.15

OCF/S Ratio 3.1%

Income Statement

Revenue $2.48B

Gross Profit $459.93M

Operating Income $-18.36M

EBITDA $-16.46M

Net Income $-18.36M

EPS (Diluted) -$0.04

Revenue / Employee $3.42M

Profit / Employee $-25.36K

Employees 724